NANOSYSTEMS BASED ON PHOSPHOLIPIDS AND SURFACTANTS AS INNOVATIVE DELIVERY SYSTEMS FOR GENE THERAPY – CIRCULAR DICHROISM STUDIES

Barbara Urban1, Michalina Skupin1, Paulina Egierska1, Joanna Wolak1, Maciej Kozak1

1 Phisics Department, Adam Mickiewicz Univerisity, Str. Umultowska 65, Poznań, Poland

Gene therapy is one of the most promising methods for treating a wide range of genetic diseases as well as cancer and neurodegenerative disorders. However the effectiveness of this method, requires the creation of effective and non-toxic methods for transferring the genetic material into a cell. Perfectly suitable for this purpose are delivery systems based on lipid-surfactant mixtures [1].

The aim of this study was to determine the possible use of amphoteric surfactants (zwitterionic alkyl derivatives of sulfobetaine [2]) and dicationic surfactants (as reference systems) as complexing agents of nucleic acids, with potential applications for gene delivery[3].

A series of measurements of the DNA conformation in selected DNA-zwitterionic surfactant and DNA-dicationic surfactant lipoplexes using the circular dichroism spectroscopy. CD spectra were recorded in the range 210-350 nm using J-815 spectrometer (Jasco). Based on the obtained results was confirmed the possibility of creating stable lipoplexes. The spectrum of the pure DNA solution exhibits a positive band near 277 nm, a negative band near 245 nm and a crossover point near 260 nm, indicating a right-handed B-DNA form (fully-hydrated). The increased surfactant concentration slightly shifted the bands towards higher wavelength. Surfactants were also shown in different kind of buffer and environment acidity.

Figure 1
Fig. 1. Measured surfactant CD spectrum.

[1] M. Barańska, and J.Skrętkowicz. Wiadomości lekarskie. vol. LX, no. 60, pp. 305-311, 2007.

[2] Edited by Chunsheng Kang, Gene Therapy - Developments and Future Perspectives, July 2011, Croatia.

[3] Allay, J.A.; Galipeau, J.; Blakley, R.L. & Sorrentino, B.P. (1998a). Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Stem Cells, Vol.16 (Suppl. 1), pp. 223-233, ISSN 1066-5099

[4] Shawn D. Wettig, Ronald E. Verrall and Marianna Foldvari, Current gene therapy, Gemini Surfactants: A New Family of Building Blocks for Non-Viral Gene Delivery Systems, vol. 8, pp. 9-23, 2011.